Author name: Rafael Patterson

BioCina and NovaCina Merger Bolsters Global CDMO Industry

BioCina Chief Executive Officer, Mark W. Womack BioCina Chief Executive Officer, Mark W. Womack [ADELAIDE, SOUTH AUSTRALIA and PERTH, WESTERN AUSTRALIA, January 14, 2025] – Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will create a powerful brand in biopharmaceutical and small molecule contract manufacturing. The combined company, […]

BioCina and NovaCina Merger Bolsters Global CDMO Industry Read More »

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

Adelaide, South Australia, October 10, 2024/– BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax, Inc., for a project involving cell line development, cell banking and plasmid DNA manufacture. Centivax is developing Cent-Flu, a universal influenza vaccine, consisting of a proprietary multivalent mixture of 22

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine Read More »